238 related articles for article (PubMed ID: 26888739)
1. Autoantigen-targeting microRNAs in Sjögren's syndrome.
Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
[TBL] [Abstract][Full Text] [Related]
2. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antiapoptotic microRNAs in primary Sjögren's syndrome.
Yang Y; Hou Y; Li J; Zhang F; Du Q
Cell Biochem Funct; 2020 Dec; 38(8):1111-1118. PubMed ID: 32575162
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
[TBL] [Abstract][Full Text] [Related]
5. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
6. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
7. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients.
Tanaka T; Warner BM; Odani T; Ji Y; Mo YQ; Nakamura H; Jang SI; Yin H; Michael DG; Hirata N; Suizu F; Ishigaki S; Oliveira FR; Motta ACF; Ribeiro-Silva A; Rocha EM; Atsumi T; Noguchi M; Chiorini JA
Sci Rep; 2020 Sep; 10(1):15169. PubMed ID: 32939030
[TBL] [Abstract][Full Text] [Related]
8. hsa-miR-424-5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients.
Carvajal P; Aguilera S; Jara D; Indo S; Barrera MJ; González S; Molina C; Heathcote B; Hermoso M; Castro I; González MJ
J Autoimmun; 2023 Jul; 138():103037. PubMed ID: 37229808
[TBL] [Abstract][Full Text] [Related]
9. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
Bachmann M; Hilker M; Grölz D; Tellmann G; Hake U; Kater L; de Wilde P; Tröster H
J Autoimmun; 1996 Dec; 9(6):757-66. PubMed ID: 9115578
[TBL] [Abstract][Full Text] [Related]
10. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2021; 12():685837. PubMed ID: 34149728
[TBL] [Abstract][Full Text] [Related]
11. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
12. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
Front Immunol; 2021; 12():697157. PubMed ID: 34367157
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
14. Distinct microRNA expression profiles in saliva and salivary gland tissue differentiate patients with primary Sjögren's syndrome from non-Sjögren's sicca patients.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
J Oral Pathol Med; 2020 Nov; 49(10):1044-1052. PubMed ID: 32799333
[TBL] [Abstract][Full Text] [Related]
15. Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.
Castro I; Carvajal P; Jara D; Aguilera S; Heathcote B; Barrera MJ; Aliaga-Tobar V; Maracaja-Coutinho V; Urzúa U; Quest AFG; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2022; 13():870094. PubMed ID: 35432384
[TBL] [Abstract][Full Text] [Related]
16. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.
Pauley KM; Stewart CM; Gauna AE; Dupre LC; Kuklani R; Chan AL; Pauley BA; Reeves WH; Chan EK; Cha S
Eur J Immunol; 2011 Jul; 41(7):2029-39. PubMed ID: 21469088
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.
Gallo A; Jang SI; Ong HL; Perez P; Tandon M; Ambudkar I; Illei G; Alevizos I
EBioMedicine; 2016 Aug; 10():216-26. PubMed ID: 27381477
[TBL] [Abstract][Full Text] [Related]
18. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
19. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.
Zilahi E; Tarr T; Papp G; Griger Z; Sipka S; Zeher M
Immunol Lett; 2012 Jan; 141(2):165-8. PubMed ID: 22033216
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
